Aicar vs Lemon Bottle

Aicar

AICAR, also called acadesine, is 5-aminoimidazole-4-carboxamide riboside: a synthetic nucleoside, not a peptide or an amino-acid derivative. Its monophosphate, ZMP, is a natural intermediate in the pathway cells use to build purine nucleotides. AICAR became a standard laboratory tool because cells convert it to ZMP, which mimics AMP and switches on AMP-activated protein kinase (AMPK). A large body of cell and rodent work has used it to study energy sensing, glucose uptake and fatty-acid metabolism. Human clinical work has been limited and has not centred on metabolism. A known weakness of the tool is that ZMP acts on other AMP-sensitive enzymes too, so not every effect attributed to AICAR runs through AMPK.

Lemon Bottle

Lemon Bottle is a proprietary multi-ingredient solution rather than a single compound, and it is not a peptide. No independently confirmed list of its ingredients and their amounts is available for this profile, so no formula, sequence or molecular weight is given. It is usually grouped with nutrient complexes made up of vitamins and metabolic cofactors, but that grouping does not establish what a given sample contains. There appears to be no peer-reviewed study of this formulation in cell models, animals or people, and no mechanism of action has been established for it.

How Aicar acts

AICAR enters cells through adenosine transporters and is phosphorylated by adenosine kinase to ZMP. ZMP binds the regulatory gamma subunit of AMPK at sites that normally sense AMP, and this allosteric activation, together with increased phosphorylation of the catalytic alpha subunit, raises the kinase's activity. Activated AMPK phosphorylates targets such as acetyl-CoA carboxylase, shifting cells away from lipid synthesis and toward processes that generate ATP. ZMP accumulates to high concentrations, however, and has been reported to affect other AMP-regulated enzymes, including fructose-1,6-bisphosphatase and glycogen phosphorylase. Studies that need to separate AMPK-dependent effects often pair AICAR with genetic knockout models.

How Lemon Bottle acts

No mechanism can be stated for a mixture whose ingredients and proportions have not been confirmed. Filing it among vitamin and cofactor complexes says nothing reliable about how any particular sample behaves. Even where individual ingredients of such mixtures have well-described biochemistry, that knowledge cannot be carried over to an undefined combination, because amounts, interactions and stability in solution all matter and none of them has been reported. No receptor, enzyme or signalling pathway has been shown in published research to mediate any action of this product, and none is implied here.

The records side by side

• Type: Aicar, Nucleoside analogue; Lemon Bottle, Proprietary mixture
• Molecular weight: Aicar, 258.23 g/mol; Lemon Bottle, not recorded
• Molecular formula: Aicar, C9H14N4O5; Lemon Bottle, not recorded

Reading a comparison

A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.